Bangladesh Core FHIR Implementation Guide
0.2.0 - Published by MoHFW Bangladesh flag

Bangladesh Core FHIR Implementation Guide - Published by Ministry of Health and Family Welfare. See the Directory of published versions

: Bangladesh Medication Dose Form CodeSystem - XML Representation

Page standards status: Informative Maturity Level: 1

Raw xml | Download


<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="bd-dose-form"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><div xml:lang="en" lang="en"><hr/><p><b>English</b></p><hr/><p class="res-header-id"><b>Generated Narrative: CodeSystem bd-dose-form</b></p><a name="bd-dose-form"> </a><a name="hcbd-dose-form"> </a><p>This  code system <code>https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">TAB<a name="bd-dose-form-TAB"> </a></td><td>Tablet</td><td>Solid oral dosage form, usually uncoated or coated, intended for swallowing.</td></tr><tr><td style="white-space:nowrap">DTAB<a name="bd-dose-form-DTAB"> </a></td><td>Dispersible Tablet</td><td>Tablet designed to be dissolved/dispersed in water before administration.</td></tr><tr><td style="white-space:nowrap">CAP<a name="bd-dose-form-CAP"> </a></td><td>Capsule</td><td>Solid dosage form with active ingredients enclosed in a gelatin shell.</td></tr><tr><td style="white-space:nowrap">SYP<a name="bd-dose-form-SYP"> </a></td><td>Syrup</td><td>Liquid oral dosage form containing active substance(s) in solution.</td></tr><tr><td style="white-space:nowrap">SUSP<a name="bd-dose-form-SUSP"> </a></td><td>Suspension</td><td>Liquid oral dosage form with insoluble particles dispersed in a liquid.</td></tr><tr><td style="white-space:nowrap">PFS<a name="bd-dose-form-PFS"> </a></td><td>Powder for Suspension</td><td>Powder that requires reconstitution into a liquid suspension before use.</td></tr><tr><td style="white-space:nowrap">INJ<a name="bd-dose-form-INJ"> </a></td><td>Injection</td><td>Sterile solution or suspension intended for parenteral administration.</td></tr><tr><td style="white-space:nowrap">SOL<a name="bd-dose-form-SOL"> </a></td><td>Solution</td><td>Liquid dosage form where drug is fully dissolved in a solvent.</td></tr><tr><td style="white-space:nowrap">CRM<a name="bd-dose-form-CRM"> </a></td><td>Cream</td><td>Semi-solid topical dosage form containing the drug in an emulsion base.</td></tr><tr><td style="white-space:nowrap">LOT<a name="bd-dose-form-LOT"> </a></td><td>Lotion</td><td>Low-viscosity liquid topical dosage form for external application.</td></tr></table></div><div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: CodeSystem bd-dose-form</b></p><a name="de-bd-dose-form"> </a><a name="de-hcbd-dose-form"> </a><p>This  code system <code>https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">TAB<a name="de-bd-dose-form-TAB"> </a></td><td>Tablet</td><td>Solid oral dosage form, usually uncoated or coated, intended for swallowing.</td></tr><tr><td style="white-space:nowrap">DTAB<a name="de-bd-dose-form-DTAB"> </a></td><td>Dispersible Tablet</td><td>Tablet designed to be dissolved/dispersed in water before administration.</td></tr><tr><td style="white-space:nowrap">CAP<a name="de-bd-dose-form-CAP"> </a></td><td>Capsule</td><td>Solid dosage form with active ingredients enclosed in a gelatin shell.</td></tr><tr><td style="white-space:nowrap">SYP<a name="de-bd-dose-form-SYP"> </a></td><td>Syrup</td><td>Liquid oral dosage form containing active substance(s) in solution.</td></tr><tr><td style="white-space:nowrap">SUSP<a name="de-bd-dose-form-SUSP"> </a></td><td>Suspension</td><td>Liquid oral dosage form with insoluble particles dispersed in a liquid.</td></tr><tr><td style="white-space:nowrap">PFS<a name="de-bd-dose-form-PFS"> </a></td><td>Powder for Suspension</td><td>Powder that requires reconstitution into a liquid suspension before use.</td></tr><tr><td style="white-space:nowrap">INJ<a name="de-bd-dose-form-INJ"> </a></td><td>Injection</td><td>Sterile solution or suspension intended for parenteral administration.</td></tr><tr><td style="white-space:nowrap">SOL<a name="de-bd-dose-form-SOL"> </a></td><td>Solution</td><td>Liquid dosage form where drug is fully dissolved in a solvent.</td></tr><tr><td style="white-space:nowrap">CRM<a name="de-bd-dose-form-CRM"> </a></td><td>Cream</td><td>Semi-solid topical dosage form containing the drug in an emulsion base.</td></tr><tr><td style="white-space:nowrap">LOT<a name="de-bd-dose-form-LOT"> </a></td><td>Lotion</td><td>Low-viscosity liquid topical dosage form for external application.</td></tr></table></div><div xml:lang="fr" lang="fr"><hr/><p><b>French</b></p><hr/><p class="res-header-id"><b>Narratif généré : CodeSystem bd-dose-form</b></p><a name="fr-bd-dose-form"> </a><a name="fr-hcbd-dose-form"> </a><p>This  code system <code>https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Définition</b></td></tr><tr><td style="white-space:nowrap">TAB<a name="fr-bd-dose-form-TAB"> </a></td><td>Tablet</td><td>Solid oral dosage form, usually uncoated or coated, intended for swallowing.</td></tr><tr><td style="white-space:nowrap">DTAB<a name="fr-bd-dose-form-DTAB"> </a></td><td>Dispersible Tablet</td><td>Tablet designed to be dissolved/dispersed in water before administration.</td></tr><tr><td style="white-space:nowrap">CAP<a name="fr-bd-dose-form-CAP"> </a></td><td>Capsule</td><td>Solid dosage form with active ingredients enclosed in a gelatin shell.</td></tr><tr><td style="white-space:nowrap">SYP<a name="fr-bd-dose-form-SYP"> </a></td><td>Syrup</td><td>Liquid oral dosage form containing active substance(s) in solution.</td></tr><tr><td style="white-space:nowrap">SUSP<a name="fr-bd-dose-form-SUSP"> </a></td><td>Suspension</td><td>Liquid oral dosage form with insoluble particles dispersed in a liquid.</td></tr><tr><td style="white-space:nowrap">PFS<a name="fr-bd-dose-form-PFS"> </a></td><td>Powder for Suspension</td><td>Powder that requires reconstitution into a liquid suspension before use.</td></tr><tr><td style="white-space:nowrap">INJ<a name="fr-bd-dose-form-INJ"> </a></td><td>Injection</td><td>Sterile solution or suspension intended for parenteral administration.</td></tr><tr><td style="white-space:nowrap">SOL<a name="fr-bd-dose-form-SOL"> </a></td><td>Solution</td><td>Liquid dosage form where drug is fully dissolved in a solvent.</td></tr><tr><td style="white-space:nowrap">CRM<a name="fr-bd-dose-form-CRM"> </a></td><td>Cream</td><td>Semi-solid topical dosage form containing the drug in an emulsion base.</td></tr><tr><td style="white-space:nowrap">LOT<a name="fr-bd-dose-form-LOT"> </a></td><td>Lotion</td><td>Low-viscosity liquid topical dosage form for external application.</td></tr></table></div></div>
  </text>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
    <valueInteger value="1">
      <extension
                 url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
        <valueCanonical
                        value="https://fhir.dghs.gov.bd/core/ImplementationGuide/bd.fhir.core"/>
      </extension>
    </valueInteger>
  </extension>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
    <valueCode value="informative">
      <extension
                 url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
        <valueCanonical
                        value="https://fhir.dghs.gov.bd/core/ImplementationGuide/bd.fhir.core"/>
      </extension>
    </valueCode>
  </extension>
  <url value="https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form"/>
  <version value="0.2.0"/>
  <name value="BDMedicationDoseForm"/>
  <title value="Bangladesh Medication Dose Form CodeSystem"/>
  <status value="draft"/>
  <date value="2025-10-06T15:46:52+00:00"/>
  <publisher
             value="Directorate General of Health Services (DGHS), Bangladesh"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="http://dghs.gov.bd"/>
    </telecom>
  </contact>
  <description
               value="Medication dose form codes according to CCDS guideline"/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="050"/>
    </coding>
  </jurisdiction>
  <content value="complete"/>
  <count value="10"/>
  <concept>
    <code value="TAB"/>
    <display value="Tablet"/>
    <definition
                value="Solid oral dosage form, usually uncoated or coated, intended for swallowing."/>
  </concept>
  <concept>
    <code value="DTAB"/>
    <display value="Dispersible Tablet"/>
    <definition
                value="Tablet designed to be dissolved/dispersed in water before administration."/>
  </concept>
  <concept>
    <code value="CAP"/>
    <display value="Capsule"/>
    <definition
                value="Solid dosage form with active ingredients enclosed in a gelatin shell."/>
  </concept>
  <concept>
    <code value="SYP"/>
    <display value="Syrup"/>
    <definition
                value="Liquid oral dosage form containing active substance(s) in solution."/>
  </concept>
  <concept>
    <code value="SUSP"/>
    <display value="Suspension"/>
    <definition
                value="Liquid oral dosage form with insoluble particles dispersed in a liquid."/>
  </concept>
  <concept>
    <code value="PFS"/>
    <display value="Powder for Suspension"/>
    <definition
                value="Powder that requires reconstitution into a liquid suspension before use."/>
  </concept>
  <concept>
    <code value="INJ"/>
    <display value="Injection"/>
    <definition
                value="Sterile solution or suspension intended for parenteral administration."/>
  </concept>
  <concept>
    <code value="SOL"/>
    <display value="Solution"/>
    <definition
                value="Liquid dosage form where drug is fully dissolved in a solvent."/>
  </concept>
  <concept>
    <code value="CRM"/>
    <display value="Cream"/>
    <definition
                value="Semi-solid topical dosage form containing the drug in an emulsion base."/>
  </concept>
  <concept>
    <code value="LOT"/>
    <display value="Lotion"/>
    <definition
                value="Low-viscosity liquid topical dosage form for external application."/>
  </concept>
</CodeSystem>